chr6-150775283-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001029884.3(PLEKHG1):c.512+6545C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0729 in 152,168 control chromosomes in the GnomAD database, including 462 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.073 ( 462 hom., cov: 32)
Consequence
PLEKHG1
NM_001029884.3 intron
NM_001029884.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.174
Publications
3 publications found
Genes affected
PLEKHG1 (HGNC:20884): (pleckstrin homology and RhoGEF domain containing G1) Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in regulation of small GTPase mediated signal transduction. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
PLEKHG1 Gene-Disease associations (from GenCC):
- periventricular leukomalaciaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0833 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PLEKHG1 | ENST00000696526.1 | c.512+6545C>T | intron_variant | Intron 4 of 16 | NM_001029884.3 | ENSP00000512689.1 | ||||
| PLEKHG1 | ENST00000475490.1 | n.53+6545C>T | intron_variant | Intron 1 of 14 | 1 | ENSP00000433107.1 | ||||
| PLEKHG1 | ENST00000358517.6 | c.512+6545C>T | intron_variant | Intron 3 of 15 | 5 | ENSP00000351318.2 | ||||
| PLEKHG1 | ENST00000644968.1 | c.512+6545C>T | intron_variant | Intron 3 of 15 | ENSP00000496254.1 |
Frequencies
GnomAD3 genomes AF: 0.0729 AC: 11085AN: 152050Hom.: 463 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
11085
AN:
152050
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0729 AC: 11087AN: 152168Hom.: 462 Cov.: 32 AF XY: 0.0715 AC XY: 5319AN XY: 74398 show subpopulations
GnomAD4 genome
AF:
AC:
11087
AN:
152168
Hom.:
Cov.:
32
AF XY:
AC XY:
5319
AN XY:
74398
show subpopulations
African (AFR)
AF:
AC:
3273
AN:
41514
American (AMR)
AF:
AC:
1333
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
249
AN:
3472
East Asian (EAS)
AF:
AC:
241
AN:
5178
South Asian (SAS)
AF:
AC:
376
AN:
4820
European-Finnish (FIN)
AF:
AC:
255
AN:
10580
Middle Eastern (MID)
AF:
AC:
51
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5040
AN:
68002
Other (OTH)
AF:
AC:
200
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
524
1048
1573
2097
2621
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
132
264
396
528
660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
183
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.